Literature DB >> 22033997

Age, antipsychotics, and the risk of ischemic stroke in the Veterans Health Administration.

Shirley Wang1, Crystal Linkletter, David Dore, Vincent Mor, Stephen Buka, Malcolm Maclure.   

Abstract

BACKGROUND AND
PURPOSE: Time-dependent effects of antipsychotics on risk of stroke and potential effect modification by age have not been fully investigated. A case-case-time-control design uses within- and between-case comparisons to evaluate short-term effects at the same time as adjusting for unmeasured time-invariant confounders and exposure-time trends.
METHODS: We conducted a case-case-time-control design study using data from the Veterans Health Administration. Veterans with inpatient hospitalizations for ischemic stroke between 2002 and 2007 were included. For every stroke case, the "current" exposure period was defined as 1 to 30 days before hospitalization and the "reference" period as 91 to 120 days before hospitalization. Exposure during the current period was compared with exposure during the reference period within cases. Exposure-time trend-adjusted estimates of the effect of antipsychotic exposure on risk of stroke were obtained by dividing exposure odds for antipsychotic exposure by average exposure odds for other medications over the same time period among the same cases.
RESULTS: After adjusting for exposure-time trends, odds of stroke were 1.8 (95% CI, (1.7-1.9) times higher when exposed to antipsychotics than when unexposed. Age-stratified estimates suggest a greater triggering effect of antipsychotics among older patients.
CONCLUSIONS: Exposure to antipsychotics may be a proximal trigger for stroke. Elevation in risk is apparent after brief exposure to antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033997     DOI: 10.1161/STROKEAHA.111.617191

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Association of quetiapine with ischemic brain stem stroke: a case report and discussion.

Authors:  Selma BozkurtZincir; Betul F Ozdilek; Serkan Zincir
Journal:  Ther Adv Psychopharmacol       Date:  2015-08

Review 2.  Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.

Authors:  Gianluca Trifiró; Janet Sultana; Edoardo Spina
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

3.  Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics.

Authors:  Ismaeel Yunusa; Chengwen Teng; Ibraheem M Karaye; Emily Crounse; Saud Alsahali; Nasim Maleki
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

Review 4.  Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.

Authors:  John W Jackson; Sebastian Schneeweiss; Tyler J VanderWeele; Deborah Blacker
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

5.  Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study.

Authors:  Alex M Cressman; Erin M Macdonald; Anjie Huang; Tara Gomes; Michael J Paterson; Paul A Kurdyak; Muhammad M Mamdani; David N Juurlink
Journal:  J Clin Psychopharmacol       Date:  2015-12       Impact factor: 3.153

6.  Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis.

Authors:  Sanja Zivkovic; Chan Hee Koh; Nandita Kaza; Caroline A Jackson
Journal:  BMC Psychiatry       Date:  2019-06-20       Impact factor: 3.630

7.  Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons.

Authors:  Marie Sahlberg; Ellen Holm; Gunnar H Gislason; Lars Køber; Christian Torp-Pedersen; Charlotte Andersson
Journal:  J Am Heart Assoc       Date:  2015-09-01       Impact factor: 5.501

8.  Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based study.

Authors:  Poul Jennum; Lone Baandrup; Helle K Iversen; Rikke Ibsen; Jakob Kjellberg
Journal:  BMJ Open       Date:  2016-03-08       Impact factor: 2.692

9.  Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study.

Authors:  Anne Bénard-Laribière; Emilie Hucteau; Stéphanie Debette; Julien Kirchgesner; Julien Bezin; Antoine Pariente
Journal:  BMJ       Date:  2022-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.